Linked Life Data

9752067

Source:http://linkedlifedata.com/resource/pubmed/id/9752067

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
26
pubmed:dateCreated
1998-11-4
pubmed:abstractText
Given its pros and cons the indication for nebulisation therapy is limited. Nebulisation is cumbersome, expensive, time-consuming and often unnecessary even during severe bronchial obstruction. Inhalation is simple with metered dose inhalers and small inhalation chambers with low or no static charge and a mask over mouth and nose. Inhalation therapy in young children can fail on many points, with the risk that treatment is considered ineffective. Good instruction and control of correct use are mandatory. Inhalation therapy for small children has to focus on effective drug delivery, particularly during conditions like dyspnoea, tachypnoea and bronchial obstruction, because otherwise the therapy will fail when most needed. Of the three inhalation chambers available for small children, viz. the Babyhaler, the Aerochamber and the metal Nebuhaler, the last two are to be preferred. Since in the near future hydrofluoroalkane (HFA) aerosols will replace chlorofluorocarbon (CFC) aerosols an increased bronchial deposition has to be taken into account.
pubmed:commentsCorrections
pubmed:language
dut
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0028-2162
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
142
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1488-93
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
[Inhalation therapy in children younger than 2 years. II. The practice].
pubmed:affiliation
Emma Kinderziekenhuis AMC, afd. Kinderpulmonologie, Amsterdam.
pubmed:publicationType
Journal Article, English Abstract, Review